In the era of genome-guided personalized cancer treatment, we must understand chemotherapyinduced genomic changes in tumors. This study evaluated whether adjuvant FOLFOX chemotherapy modifies the mutational profile of recurrent colorectal cancer (CRC). | Comparative sequence analysis of patientmatched primary colorectal cancer metastatic and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy